Blood-Brain Barrier Penetration of Therapeutic Agents in Human

NCT04571996 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

4

Enrollment

INDUSTRY

Sponsor class

Conditions

CNS Disease

Interventions

DRUG: ODM-104
DRUG: Paracetamol

Sponsor

Orion Corporation, Orion Pharma